KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xerox Holdings (XRX) Asset Writedowns and Impairment: 2021-2024

Historic Asset Writedowns and Impairment for Xerox Holdings (XRX) over the last 2 years, with Sep 2024 value amounting to $1.0 million.

  • Xerox Holdings' Asset Writedowns and Impairment fell 90.91% to $1.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $51.0 million, marking a year-over-year increase of 34.21%. This contributed to the annual value of $27.0 million for FY2024, which is 25.00% down from last year.
  • Xerox Holdings' Asset Writedowns and Impairment amounted to $1.0 million in Q3 2024, which was down 96.15% from $26.0 million recorded in Q1 2024.
  • Xerox Holdings' 5-year Asset Writedowns and Impairment high stood at $26.0 million for Q1 2024, and its period low was $1.0 million during Q1 2022.
  • In the last 3 years, Xerox Holdings' Asset Writedowns and Impairment had a median value of $10.0 million in 2022 and averaged $8.9 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first spiked by 1,100.00% in 2023, then slumped by 90.91% in 2024.
  • Quarterly analysis of 4 years shows Xerox Holdings' Asset Writedowns and Impairment stood at $3.0 million in 2021, then surged by 66.67% to $5.0 million in 2022, then soared by 160.00% to $13.0 million in 2023, then tumbled by 90.91% to $1.0 million in 2024.
  • Its Asset Writedowns and Impairment stands at $1.0 million for Q3 2024, versus $26.0 million for Q1 2024 and $13.0 million for Q4 2023.